Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors

Abstract

In the largest evaluation of fatal ICI-associated toxic effects published to date to our knowledge, we observed early onset of death with varied causes and frequencies depending on therapeutic regimen. Clinicians across disciplines should be aware of these uncommon lethal complications.

Keywords

MeSH Terms

Affiliated Institutions

• Massachusetts General Hospital US
• Assistance Publique – Hôpitaux de Paris FR
• Northwestern University US
• Inserm FR
• University Hospital Heidelberg DE
• Sorbonne Université FR
• Fondation pour l’innovation en Cadiométabolisme et Nutrition FR
• Mater Health Services AU
• Moffitt Cancer Center US
• Pitié-Salpêtrière Hospital FR
• National Center for Tumor Diseases DE
• Royal North Shore Hospital AU
• The University of Sydney AU
• Westmead Hospital AU
• Vanderbilt University Medical Center US
• Heidelberg University DE
• Melanoma Institute Australia AU
• Blacktown & Mount Druitt Hospital AU

Related Publications